Navigation Links
OmniComm Systems, Inc. Hosts Autumn 2010 eClinical Forum Meeting

FORT LAUDERDALE, Fla., Sept, 21 /PRNewswire/ -- OmniComm Systems, Inc. (OTC Bulletin Board: OMCM), a global provider of eClinical solutions and services announced that it will be hosting the autumn eClinical Forum US semiannual meeting at the Hilton Beach Resort in Fort Lauderdale, Florida from November 03-05, 2010. The eClinical Forum will feature presentations and speakers from participating Life Science organizations. The informal ambiance provides support for its participants to interchange ideas, information, and best practices that enhance the understanding of  evolving research information and technology trends.  The eClinical Forum allows its participants to work together and discuss their concerns and ideas openly. The collaboration between OmniComm and eClinical Forum will continue to embody the values of maintaining open communication, furthering the knowledge and awareness of relevant eClinical topics

"The eClinical Forum is unique in the way that information is shared amongst companies", stated Ken Light, Executive Vice President of Operations for OmniComm Systems. "Ultimately, the entire industry benefits from the open exchange.  We are pleased to have been long-standing members and participants in this progressive organization".

"We are all looking forward to this November's workshop being hosted in Fort Lauderdale,"  said Suzanne Bishop, US Facilitator of eClinical Forum.  "OmniComm has been a strong contributor in the eClinical Forum, and an active participant on our steering committee.  We are very pleased that they have chosen to host our Autumn workshop near their Fort Lauderdale headquarters."

The autumn meeting will include facilitated sessions on current issues with investigator portals, adverse event reporting, source data verification and eSource, and integration with Electronic Health Records.

About eClinical ForumThe Forum ( was founded in 2000 with the idea to discuss all areas of eClinical and Electronic Data capture. There are more than 50 companies that are members of the eClinical Forum, a transatlantic association. They include companies from both Pharmaceutical and related industries. There goal is to provide "practical information, approach and learning experiences required to maximize the success of the eClinical initiatives." Funding is solely based on the contributions from their members, which allows them to unbiasedly discuss any interest of their members. The advantage of becoming part of eClinical Forum is its panoptic collection of information solely available to its members.

About OmniCommOmniComm Systems, Inc. ( provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's pricing model is easily understood and allows companies ranging from small, to large, to maximize their clinical research investments. OmniComm Systems, Inc has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.

Safe Harbor DisclaimerStatements made by OmniComm included in this release may constitute forward-looking statements within the
meaning of the Private Securities Litigation Reform Act of 1995. Such statements involve a number of risks and uncertainties such as the Company's ability to obtain new contracts and accurately estimate net revenues due to uncertain regulatory guidance, variability in size, scope and duration of projects, and internal issues at the sponsoring client, integration of acquisitions, competitive factors, technological development, and market demand. As a result, actual results may differ materially from any financial outlooks stated herein. Further information on potential factors that could affect the Company's financial results can be found in the Company's Reports on Form 10-K and 10-Q filed with the Securities and Exchange Commission. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events, or otherwise. CONTACT:Ken LightOmniComm Systems,

SOURCE OmniComm Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sarah Cannon Research Institute Selects OmniComm Systems Electronic Data Capture Solution, TrialMaster(TM), for Clinical Trials Management
2. Amarex Clinical Research Selects OmniComm Systems to Provide eClinical Solutions for Phase III Medical Device Study and Joins OmniComms CRO Preferred Program
3. Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease
4. OmniComm Systems, Inc. Announces 2010 First Half Results
5. OmniComm Systems Announces Auditor Change
6. SELECT TRIAL Used Selenomethionine Instead of High-Selenium Yeast, SelenoExcell(R) - Previous Research has Shown SelenoExcell(R) Supplementation to Reduce Lung, Colon and Prostate Cancers by as Much as 63%, Says Cypress Systems, Inc.
7. Guided Delivery Systems, Inc. Successfully Treats First Patient with Mitral Regurgitation
8. Delcath Systems, Inc. Appoints Dr. Krishna Kandarpa its Executive Vice President R&D and Chief Medical Officer
9. Delcath Systems, Inc. Completes Phase III Study Enrollment
10. Delcath Systems, Inc. to Present at the 12th Annual Needham Growth Stock Conference
11. Delcath Systems, Inc. Prices $30.6 Million Stock Offering
Post Your Comments:
(Date:11/26/2015)... Nov. 26, 2015 Research and Markets ... the "2016 Future Horizons and Growth Strategies ... Supplier Shares, Country Segment Forecasts, Competitive Intelligence, Emerging ... --> --> This ... the Italian therapeutic drug monitoring market, including emerging ...
(Date:11/25/2015)... , Nov. 25, 2015  Amgen (NASDAQ: AMGN ... Application (BLA) with the United States ... 501, a biosimilar candidate to Humira ® (adalimumab). ... application submitted to the FDA and represents Amgen,s first ... Sean E. Harper , M.D., executive vice president of ...
(Date:11/25/2015)... Nov. 25, 2015  ARKRAY USA ... to provide evidence demonstrating the accuracy of its blood ... on Insulin Resistance, Diabetes and Cardiovascular Disease in ... the Company,s GLUCOCARD ® 01 meter and the ... requirements. The ability to accurately measure glucose levels in ...
Breaking Medicine Technology:
(Date:11/28/2015)... ... , ... Safe storage for contraceptive devices may not always be easy to ... and the other from Bradley Beach, New Jersey, there is an easy solution to ... to replace NuvaRings more often than necessary. As such, it affords peace of mind ...
(Date:11/27/2015)... ... November 28, 2015 , ... There is only one major question facing ... last year? , This question has not been an easy question to answer. Especially ... age and the younger workforce don’t share the same discipline around working long hours. ...
(Date:11/27/2015)... ... 27, 2015 , ... The rapid speed at which Americans ... more care is needed, especially with Alzheimer’s, dementia and other cognitive conditions becoming ... The forgotten part of this equation: 80 percent of medical care occurs in ...
(Date:11/27/2015)... ... 27, 2015 , ... Lizzie’s Lice Pickers just announced a special promotion that ... of their purchase of lice treatment product. In addition, customers will receive a complimentary ... spokesperson. “Finding lice is a sure way to ruin the holidays, so we encourage ...
(Date:11/27/2015)... , ... November 27, 2015 , ... ... of progress through sharing, the 2016 Building Better Radiology Marketing Programs ... will begin on Sunday, March 6, 2016, at Caesars Palace in Las Vegas ...
Breaking Medicine News(10 mins):